Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Liraglutide on Hemodynamics in Heart Failure
NCT02490176Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of liraglutide in heart failure (HF) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Change in Cardiac Output at 7 days. Status: unknown.
02
Drugs
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02490176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02490176.